Sign in
Taking people in United StatesPhase 2

Stool transplant from a selected donor for irritable bowel syndrome

Tests donor stool transplants in adults with irritable bowel syndrome and high protein breakdown.

Key facts

Who runs it
Madhusudan (Madhu) Grover, MBBS
Where
Rochester, United StatesSee the site
Trial code
Registry title
Fecal Microbiota Transplantation for IBS
Status
Recruiting
Phase
Phase 2
People taking part
43 people, planned
Started
15 Apr 2024
Expected to end
26 Jun 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Donor Fecal Microbiota Transplantation
  • Autologous Fecal Microbiota Transplantation
Record updated
8 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women with irritable bowel syndrome (IBS) with moderate to severe symptoms, not the constipation type. They will get a stool transplant from a donor or from their own stool.

Age
18 Years to 70 Years
Sex
Women only
Disease stage
IBS by Rome IV criteria, not the constipation-predominant type (non IBS-C). Moderate to severe symptoms, IBS-SSS score of 175 or more.
Earlier treatment
No new probiotics, antibiotics or NSAIDs within 4 wks before the study. No treatments that affect bowel movement, except loperamide. No immunosuppressive medicines.

Main reasons for not taking part

  • Weak immune system, active cancer, or chronic kidney or liver disease
  • Pregnant or breastfeeding
  • Other bowel diseases such as IBD, celiac disease or microscopic colitis
  • Severe psychiatric disorder (HADS-A or D>16), or alcohol or drug abuse disorder
  • Past abdominal surgery, apart from the listed exceptions, or a bleeding disorder

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • IBS defined by Rome IV criteria
  • Non IBS-C
  • Moderate to severe symptoms defined by IBS-SSS≥175
  • Able to safely undergo and consent to colonoscopy

Who cannot take part

  • Immune deficiency or treatment with immunosuppressive medications
  • Abdominal surgery (exception of splenectomy, partial hepatectomy, partial/unilateral nephrectomy, laparoscopy, pelvic floor repair, mesh, liposuction, fundoplication, tubal ligation, gastric sleeve, oophorectomy, hernia, appendectomy, cholecystectomy, caesarean section and hysterectomy)
  • New probiotics or treatment with antibiotics, NSAIDs (within 4 wks prior to study entry)
  • Severe bowel or medical disease precluding administration of bowel prep
  • Severe bowel or medical disease precluding colonoscopy with conscious sedation
  • Active cancer
  • Severe psychiatric disorder (HADS-A or D>16), or diagnosed alcohol or drug abuse disorder
  • Diagnosed h/o bleeding disorder
  • Organic GI diseases (IBD, celiac disease, microscopic colitis)
  • Chronic kidney or liver disease
  • Absolute neutrophil count (ANC) <500 IU/ml
  • Pregnant or lactating
  • Use of treatments known to affect colonic motility (with exception of loperamide)

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Where in United States

  • Mayo Clinic in MinnesotaRochester, United StatesContact: Jonah Pedelty, MSTaking people

About the trial

What the trial wants to find out

The purpose of this study is to learn the efficacy and safety of fecal microbiota transplantation (FMT) using stool from a donor with low proteolytic activity and containing the bacteria Alistipes putredinis in patients with irritable bowel syndrome (IBS) and high proteolytic activity. Proteolytic activity is the breakdown of proteins into smaller polypeptides or amino acids.

The 2 groups in the trial

  • Donor Fecal Microbiota Transplantation GroupTreatment being tested

    Subjects will receive a fecal microbiota transplantation (FMT) using stool from a donor

    Treatment: Donor Fecal Microbiota Transplantation

  • Autologous Fecal Microbiota Transplantation GroupPlacebo, for comparison

    Subjects will receive a fecal microbiota transplantation (FMT) using their own stool

    Treatment: Autologous Fecal Microbiota Transplantation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Efficacy and Safety of Proteolytic Activity-Guided Fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT Trial)
Plain-language title
Stool transplant from a selected donor for irritable bowel syndromeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05776914, who can take part
Record updated
8 May 2026